BACIL PHARMA LTD. Share Price

BACIL PHARMA LTD. Share Price

BSE: 524516
|
Pharmaceuticals
|
S Cap
₹ 13.89
+₹0.66 (4.99%)
1D
Last updated 02 Sep, 2026, 15:11 IST

BACIL PHARMA LTD. Share Price Today

As of 3 Sep 2026, BACIL PHARMA LTD. share price is ₹13.89. The stock opened at ₹13.30, compared to its previous close of ₹13.23. During today's trading session, BACIL PHARMA LTD. share price moved in the range of ₹13.00 to ₹13.89, with an average price of ₹13.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹10.65 and a high of ₹61.80.

₹13.00
4.99% up today
₹13.89
1D LOW
1D HIGH

BACIL PHARMA LTD. Returns Calculator

Circuit
L
H
₹12.57
₹13.89
52-week
L
H
₹10.65
₹61.80

About BACIL PHARMA LTD.

BACIL PHARMA LTD. Share Price
ISIN
INE711D01018
Sector Market Cap
₹ 18.99 Cr

Bacil Pharma Limited is an India-based pharmaceutical company, which is engaged in the business of manufacturing of pharmaceuticals, medicinal chemicals and botanical products. The Company operates as a manufacturer, exporter, supplier and retailer of a range of anti-anxiety medicine, antihistamines, chemical compound, drugs, and herbal tablets and capsules.

BACIL PHARMA LTD. Financial Highlights

  • Revenue: BACIL PHARMA LTD. reported revenue of ₹1.24 crore in FY26 vs ₹0.66 crore in FY25. It showed an increase of 87.88% on a yearly basis.
  • Operating Profit: BACIL PHARMA LTD. reported an operating profit of ₹0.99 crore in FY26 vs ₹0.41 crore in FY25. It showed an increase of 141.46% on a year-on-year basis.
  • Net Profit: BACIL PHARMA LTD. reported a net profit of ₹1.56 crore in FY26 vs ₹0.40 crore in FY25. It showed an increase of 290.00% on a yearly basis.

BACIL PHARMA LTD. Quarterly Result Highlights

  • BACIL PHARMA LTD. reported revenue of ₹0.09 crore in Jun 2026, compared with ₹0.11 crore in Mar 2026, representing a decrease of 18.18% on a quarter-on-quarter (QoQ) basis.
  • BACIL PHARMA LTD. reported an operating profit of ₹0.07 crore in Jun 2026, compared with ₹0.04 crore in Mar 2026, representing an increase of 75.00% on a quarter-on-quarter (QoQ) basis.
  • BACIL PHARMA LTD. reported a loss of ₹0.02 crore in Jun 2026, compared with ₹0.62 crore in Mar 2026, reflecting a decrease of 103.23% on a QoQ basis.
  • The earnings per share (EPS) of BACIL PHARMA LTD. stood at ₹0.64 during Jun 2026.
Know more
Promoters
0.00%
FII
0.00%
Other DII
0.00%
Retail and other
100.00%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
18.99
P/E
30.20
P/B
0.79
ROE
6.27%
D/E
0.00
ROCE
3.99%
Div. Yield
0.00%
EPS(TTM)
1.11
Turnover
0.00
EV/EBITDA
108.36
Net Margin
0.00%
Op. Margin
0.00%
ROA
2.37%
Quick Ratio
0.00
Curr. Ratio
0.68
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Bacil Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Bacil Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,180.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,43,302.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,623.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,498.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories97,741.0030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.145.9811.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma96,836.1025.682.529.25%0.1911.76%394.820.24%0.3841.58

BACIL PHARMA LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.00₹0.00₹0.00₹0.00
Other Income₹0.66₹0.13₹0.11₹0.06
Total Revenue₹0.66₹0.13₹0.11₹0.06
Total Expenses₹0.25₹0.19₹0.22₹3.92
Profit Before Tax₹0.41-₹0.06-₹0.10-₹3.86
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax₹0.40-₹0.06-₹0.10-₹3.86
EPS - Basic₹0.64-₹0.10-₹0.17-₹6.55
EPS - Diluted₹0.64-₹0.10-₹0.17-₹6.55

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹0.41-₹0.06-₹0.10-₹3.86
Income before WC changes₹0.38-₹0.09-₹0.13-₹3.91
Change in Assets-₹0.04₹0.00₹0.00₹0.05
Change in Liabilities₹0.06₹0.09-₹0.02-₹0.15
Change in WC₹0.02₹0.08-₹0.02-₹0.10
Cash flow from Operations₹0.40₹0.00-₹0.15-₹4.01
Cash flow from Investing₹0.34₹0.08-₹0.12₹3.81
Cash flow from Financing₹2.08-₹0.06₹0.06₹0.33
Total Cash Flow₹2.82₹0.01-₹0.20₹0.13
Cash (Start of the year)₹0.04₹0.03₹0.23₹0.10
Cash (End of the year)₹2.86₹0.04₹0.03₹0.23

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹22.69₹1.27₹0.90₹0.96
Current Assets₹2.91₹0.05₹0.23₹0.32
Total Assets₹25.60₹1.33₹1.13₹1.27
Current Liabilities₹0.17₹0.11₹0.03₹0.05
Net Current Asset₹2.74-₹0.06₹0.20₹0.27
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹25.43₹1.21₹1.10₹1.22
Total Equity & Liabilities₹25.60₹1.33₹1.13₹1.27
* All values are in INR Crore
Qty
Bid
8062
13.89
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 8062
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
33.7
Neutral
ATR (14)
0.85
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
60.99
Bearish
UO(9)
60.11
Neutral
ROC(12)
11.39
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
12.63
12.92
10D
12.19
12.84
20D
13.26
14.84
50D
25.24
23.44
100D
38.71
31.82
Volume trend — traded volume by day
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug1L
27 Aug0L
Average0L
Compare against other stocks
BACIL PHARMA LTD. Share Price
BACIL PHARMA LTD.
Pharmaceuticals
Add Stock
Add Another

BACIL PHARMA LTD. Share Price FAQs